Saltar al contenido
Merck

Discovery of potent non-urea inhibitors of soluble epoxide hydrolase.

Bioorganic & medicinal chemistry letters (2009-03-24)
Yuli Xie, Yidong Liu, Gangli Gong, Deborah H Smith, Fang Yan, Alison Rinderspacher, Yan Feng, Zhengxiang Zhu, Xiangpo Li, Shi-Xian Deng, Lars Branden, Dusica Vidović, Caty Chung, Stephan Schürer, Christophe Morisseau, Bruce D Hammock, Donald W Landry
RESUMEN

Soluble epoxide hydrolase (sEH) is a novel target for the treatment of hypertension and vascular inflammation. A new class of potent non-urea sEH inhibitors was identified via high throughput screening (HTS) and chemical modification. IC(50)s of the most potent compounds range from micromolar to low nanomolar.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Methyl isonipecotate, technical grade